Current treatment of potentially resectable pancreatic ductal adenocarcinoma: a medical oncologist's perspective
VHF de Jesus, RP Riechelmann - Cancer Control, 2023 - journals.sagepub.com
Pancreatic cancer has traditionally been associated with a dismal prognosis, even in early
stages of the disease. In recent years, the introduction of newer generation chemotherapy …
stages of the disease. In recent years, the introduction of newer generation chemotherapy …
[HTML][HTML] Systemic treatments in pancreatic cancer: Taiwan pancreas society recommendation
YY Su, NJ Chiang, TJ Chiu, CJ Huang, SJ Hsu… - Biomedical Journal, 2023 - Elsevier
Pancreatic cancer is a highly aggressive malignancy with a poor prognosis. Over the past
decade, significant therapeutic advancements have improved the survival rates of patients …
decade, significant therapeutic advancements have improved the survival rates of patients …
Impact of time from diagnosis to chemotherapy on prognosis in advanced pancreatic cancer
T Nishida, A Sugimoto, K Hosokawa… - Japanese Journal of …, 2024 - academic.oup.com
Background Due to the aggressive nature and poor prognosis of advanced pancreatic
cancer, prompt initiation of treatment is critical. We investigated the effect of the interval …
cancer, prompt initiation of treatment is critical. We investigated the effect of the interval …
R1 pancreatic cancer patients benefit from chemoradiation when initiation of adjuvant therapy is delayed
Background Adjuvant chemotherapy (AC) following pancreaticoduodenectomy (PD) for
pancreas cancer (PDAC) has been demonstrated to improve survival. However, the optimal …
pancreas cancer (PDAC) has been demonstrated to improve survival. However, the optimal …
Effect of postsurgical adjuvant chemotherapy timing on outcomes in patients with pancreatic cancer–a systematic review and meta-analysis
L Zhou, L Zhang - Journal of Chemotherapy, 2024 - Taylor & Francis
To assess the association between the timing of postsurgical adjuvant chemotherapy and
overall survival (OS) and disease-free survival (DFS) in patients with pancreatic cancer (PC) …
overall survival (OS) and disease-free survival (DFS) in patients with pancreatic cancer (PC) …
Time to neoadjuvant chemotherapy initiation is not associated with survival in pancreatic cancer
Introduction Not all patients with pancreatic adenocarcinoma (PDAC) tolerate multiagent
neoadjuvant chemotherapy (NAC). We utilized institutional data and the National Cancer …
neoadjuvant chemotherapy (NAC). We utilized institutional data and the National Cancer …